AMEX
0.43USD
-0.02 (-5.03%)
We have scored 6 news catalysts on cbdMD, Inc. (YCBD) over the past 12 months. The biggest single-day move next to one of them came Sep 25, 2025, when YCBD closed −10.0%: “cbdMD Announces Inferno Freeze: Our Most Powerful Topical”. Coverage across the window leans positive (average ticker sentiment +0.52). Most of the impact sits in sector consumer and downstream customer concentration.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
4.5M
P/E
—
EPS
—
Beta
2.17
52W range
0.41-2.56
Day range
0.43–0.44
Open
0.44
Prev close
0.46
Volume
78.4K
Avg volume
255.5K
Dividend
0.00
IPO
2017-11-17
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about cbdMD, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for YCBD: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.
